...
首页> 外文期刊>CNS neuroscience & therapeutics. >Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma
【24h】

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma

机译:收缩:受体酪氨酸激酶AXL与预后差并诱导胶质母细胞瘤中的灭菌血液抗性相关

获取原文
           

摘要

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma, CNS Neuroscience & Therapeutics 2019, ( https://doi.org/10.1111/cns.13227 ). The above article published online on 02 October 2019 in Wiley Online Library ( wileyonlinelibrary.com ), has been retracted by agreement between the authors, the journal Editor in Chief Jun Chen, and John Wiley & Sons Ltd. The retraction has been agreed due to unreliable data and consequently its misleading results and conclusions.
机译:收缩:受体酪氨酸激酶AXL与预后差和诱导锭剂血液母细胞瘤,CNS神经科学和治疗方法诱导替莫唑胺抗性相关,(HTTPS://DO.ORG/10.1111/CNS.13227)。上面的文章在线发表于2019年10月2日在Wiley在线图书馆(WileyonlinElibrary.com),由作者之间的协议,Jun Chen首席编辑和John Wiley&Sons Ltd.的委托签订了撤回罪名已通过不可靠的数据,因此其误导性的结果和结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号